Enfermedades gastrointestinales y hepáticas

Foto de Enfermedades gastrointestinales y hepáticas

Foto de King's College Hospital NHS Foundation Trust

King's College Hospital NHS Foundation Trust

Londres, Reino Unido

Publications in collaboration with researchers from King's College Hospital NHS Foundation Trust (2)

2019

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170

2015

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe
HIV Medicine, Vol. 16, Núm. 9, pp. 544-552